Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 8, 2006, Pages 2650-2657

  Clemons, Karl V ^a,b,c   Gonzalez, Gloria M ^a   Singh, Gaurav ^a   Imai, Jackie ^a   Espiritu, Marife ^a   Parmar, Rachana ^a   Stevens, David A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; ITRACONAZOLE; TRIAMCINOLONE ACETONIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDIASIS; CECUM; CHEMOTHERAPY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFICACY; ESOPHAGUS; FEMALE; FUNGUS TRANSMISSION; GASTROINTESTINAL MUCOSA; INTESTINE MUCOSA; KIDNEY INFECTION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; STOMACH;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; IMMUNOSUPPRESSIVE AGENTS; ITRACONAZOLE; MICE; MICE, INBRED STRAINS; MODELS, BIOLOGICAL; MUCOUS MEMBRANE; VISCERA;

EID: 33746888700     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00530-06     Document Type: Article

References (47)

1. Anaissie, E., and H. Pinczowski. 1993. Invasive candidiasis during granulocytopenia. Recent Results Cancer Res. 132:137-145.
2. Anaissie, E. J., and G. P. Bodey. 1990. Fungal infections in patients with cancer. Pharmacotherapy 10:164S-169S.
3. Bendel, C. M., S. M. Wiesner, R. M. Garni, E. Cebelinski, and C. L. Wells. 2002. Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone. Pediatr. Res. 51:290-295.
4. Clemons, K. V., J. L. Spearow, R. Parmar, M. Espiritu, and D. A. Stevens. 2004. Genetic susceptibility of mice to Candida albicans vaginitis correlates with host estrogen sensitivity. Infect. Immun. 72:4878-4880.
5. Clemons, K. V., and D. A. Stevens. 2001. Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice. Antimicrob. Agents Chemother. 45:3433-3436.
6. Clemons, K. V., and D. A. Stevens. 2001. Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis. J. Antimicrob. Chemother. 47:183-186.
7. Clemons, K. V., and D. A. Stevens. 2000. Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony stimulating factor or interferon-γ. Med. Mycol. 38:213-219.
8. Cole, G. T., A. A. Halawa, and E. J. Anaissie. 1996. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin. Infect. Dis. 22(Suppl. 2):S73-S88.
9. DeMaria, A., H. Buckley, and F. von Lichtenberg. 1976. Gastrointestinal candidiasis in rats treated with antibiotics, cortisone, and azathioprine. Infect. Immun. 13:1761-1770.
10. Ekenna, O., and R. J. Sherertz. 1987. Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice. Infect. Immun. 55:1558-1563.
11. + T-cell-deficient mice for evaluation of antifungal agents. Antimicrob. Agents Chemother. 40:1604-1609.
12. Hanson, L. H., A. M. Perlman, K. V. Clemons, and D. A. Stevens. 1991. Synergy between cilofungin and amphotericin B in a murine model of candidiasis. Antimicrob. Agents Chemother. 35:1334-1337.
13. Hector, R. F., and J. E. Domer. 1983. Control of systemic spread of Candida albicans with ketoconazole in the stomachs of mice treated with cytarabine. J. Infect. Dis. 147:946-950.
14. Herrera, C., and M. N. Guentzel. 1982. Mice with persistent gastrointestinal Candida albicans as a model for antifungal therapy. Antimicrob. Agents Chemother. 21:51-53.
15. Hoeprich, P., and P. Finn. 1972. Obfuscation of the activity of antifungal antimicrobics by culture media. J. Infect. Dis. 126:353-361.
16. Hostetler, J. S., L. H. Hanson, and D. A. Stevens. 1992. Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob. Agents Chemother. 36:477-480.
17. Hostetler, J. S., L. H. Hanson, and D. A. Stevens. 1993. Effect of hydroxypropyl-beta-cyclodextrin on efficacy of oral itraconazole in disseminated murine cryptococcosis. J. Antimicrob. Chemother. 32:459-463.
18. Kamai, Y., M. Kubota, T. Hosokawa, T. Fukuoka, and S. G. Filler. 2001. New model of oropharyngeal candidiasis in mice. Antimicrob. Agents Chemother. 45:3195-3197.
19. Kinsman, O. S., and K. Pitblado. 1989. Candida albicans gastrointestinal colonization and invasion in the mouse: effect of antibacterial dosing, antifungal therapy and immunosuppression. Mycoses 32:664-674.
20. Lachin, J. M. 1999. Worst-rank score analysis with informatively missing observations in clinical trials. Controlled Clin. Trials 20:408-422.
21. Mahfouz, T., and E. Anaissie. 2003. Prevention of fungal infections in the immunocompromised host. Curr. Opin. Investig. Drugs 4:974-990.
22. Maraki, S., D. Bafaloukos, I. Chatzinikolaou, G. Datseris, and G. Samonis. 1998. Gut colonization of mice by yeast: effects of methylprednisolone and antibiotics. Hepato-Gastroenterology 45:119-122.
23. Morrison, C. J., and D. A. Stevens. 1990. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis. Antimicrob. Agents Chemother. 34:746-750.
24. O'Brien, S. N., N. M. Blijlevens, T. H. Mahfouz, and E. J. Anaissie. 2003. Infections in patients with hematological cancer: recent developments. Hematology 1:438-472.
25. Pappas, P. G., J. H. Rex, J. D. Sobel, S. G. Filler, W. E. Dismukes, T. J. Walsh, and J. E. Edwards. 2004. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38:161-189.
26. Polak, A. 1998. Experimental models in antifungal chemotherapy. Mycoses 41:1-30.
27. Ponnuvel, K. M., C. P. Rama, and T. Menon. 1993. Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy. Indian J. Exp. Biol. 31:450-452.
28. Rex, J. H., T. J. Walsh, and E. J. Anaissie. 1998. Fungal infections in iatrogenically compromised hosts. Adv. Intern. Med. 43:321-371.
29. Samaranayake, Y. H., and L. P. Samaranayake. 2001. Experimental oral candidiasis in animal models. Clin. Microbiol. Rev. 14:398-429.
30. Samonis, G., E. J. Anaissie, and G. P. Bodey. 1990. Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob. Agents Chemother. 34:2420-2422.
31. Samonis, G., H. Anastassiadou, M. Dassiou, Y. Tselentis, and G. P. Bodey. 1994. Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans. Antimicrob. Agents Chemother. 38:602-603.
32. Samonis, G., and D. Bafaloukos. 1992. Fungal infections in cancer patients: an escalating problem. In Vivo 6:183-193.
33. Samonis, G., M. Dassiou, and H. Anastassiadou. 1994. Antibiotics affecting gastrointestinal colonization of mice by yeasts. J. Chemother. 6:50-52.
34. Samonis, G., N. C. Karyotakis, E. J. Anaissie, E. Barbounakis, S. Maraki, Y. Tselentis, and G. P. Bodey. 1996. Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans. Antimicrob. Agents Chemother. 40:2221-2223.
35. Sandovsky-Losica, H., L. Barr-Nea, and E. Segal. 1992. Fatal systemic candidiasis of gastrointestinal origin: an experimental model in mice compromised by anti-cancer treatment. J. Med. Vet. Mycol. 30:219-231.
36. Sandovsky-Losica, H., and E. Segal. 1990. Interaction of Candida albicans with murine gastrointestinal mucosa from methotrexate and 5-fluorouracil treated animals: in vitro adhesion and prevention. J. Med. Vet. Mycol. 28:279-287.
37. Sandovsky-Losica, H., and E. Segal. 1989. Interaction of Candida albicans with murine gastrointestinal mucosa: effect of irradiation on adherence in vitro. J. Med. Vet. Mycol. 27:345-352.
38. Selitrennikoff, C. P., L. Alex, T. K. Miller, K. V. Clemons, M. I. Simon, and D. A. Stevens. 2001. COS-1, a putative two-component histidine kinase of Candida albicans, is an in vivo virulence factor. Med. Mycol. 39:69-74.
39. Shih, W. 2002. Problems in dealing with missing data and informative censoring in clinical trials. Curr. Control Trials Cardiovasc. Med. 3:4.
40. Stevens, D. A., L. Calderon, M. Martinez, K. V. Clemons, S. J. Wilson, and C. P. Selitrennikoff. 2002. Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model. J. Antimicrob. Chemother. 50:361-364.
41. Stiller, R. L., J. E. Bennett, H. J. Scholer, M. Wall, A. Polak, and D. A. Stevens. 1983. Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J. Infect. Dis. 147:1070-1077.
42. Thienpont, D., J. Van Cutsem, and M. Borgers. 1980. Ketoconazole in experimental candidosis. Rev. Infect. Dis. 2:570-577.
43. Thienpont, D., J. van Cutsem, and D. A. Gough. 1978. Treatment of gastrointestinal candidosis in predisposed guinea-pigs and in conventional mice with miconazolc. Mykosen 21:417-424.
44. Troke, P. F., R. J. Andrews, K. W. Brammer, M. S. Marriott, and K. Richardson. 1985. Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice. Antimicrob. Agents Chemother. 28:815-818.
45. Wingard, J. R., J. D. Dick, W. G. Merz, G. R. Sandford, R. Saral, and W. H. Burns. 1982. Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice. Infect. Immun. 37:833-836.
46. Wingard, J. R., J. D. Dick, W. G. Merz, G. R. Sandford, R. Saral, and W. H. Burns. 1980. Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect. Immun. 29:808-813.
47. Wong, B., K. L. Brauer, J. R. Clemens, and S. Beggs. 1990. Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine. Infect. Immun. 58:283-288.